Regeneron and Tessera Therapeutics to Jointly Develop TSRA-196, an Investigational Gene ...

TSRA-196 is a potential one-time treatment to precisely correct the genetic mutation underlying AATD, with Investigational New Drug filing ...

Effects Of Long-Term Exposure To Pollution On Your Respiratory Health

Long-term exposure to pollution acts like a slow poison, but prevention remains the most effective cure. Strengthening your ...
Le Lézard

National Health Orgs: Flu Shots Critical for Individuals with Diabetes, Heart and Lung Disease

To kick off National Influenza Vaccination Week (December 1 - 6), the American Heart Association®, American Lung Association®, American Diabetes Association® (ADA) and National Foundation for ...

Regeneron Pharmaceuticals, Inc.: Dupixent (dupilumab) Approved as the First Targeted ...

Approval based on Phase 3 trials showing Dupixent significantly reduced itch and hives at 24 weeks compared to placebo In the EU, there are approximately 270,000 adults and adolescents aged 12 years ...

Dupixent® (dupilumab) Approved as the First Targeted Medicine in the European Union (EU ...

Approval based on Phase 3 trials showing Dupixent significantly reduced itch and hives at 24 weeks compared to placebo In the EU, there are ...
Le Lézard

Minutes from Extraordinary General Meeting in FluoGuide A/S

KØBENHAVN, DK / ACCESS Newswire / November 24, 2025 / FluoGuide A/S (STO:FLUO)("FluoGuide" or the "Company" held an extraordinary general meeting on 24 November 2025.To the shareholders of FluoGuide A ...